Fritextsökning
Innehållstyper
-
Pfizer väntas backa
Tidsfristen för Pfizer att lägga ett bud på Astrazeneca löper ut i dag och inget nytt bud verkar finnas på horisonten.
-
Finansiering och riskkapital i fokus: "Rätt tid att investera i biotech"
Sverige och Danmark är topprankade i EU när det gäller medicinsk innovation – men inte lika bra på att göra något av idéerna. "Det finns ett gap på den nordiska...
-
Google ska hjälpa forskarna med Big Data
It-jätten fortsätter satsa på hälsa och medicinsk forskning med molntjänsten Google Genomics.
-
Focusing on Medicon Valley
Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...
-
Bioreactor features disposable sensors
The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.
-
High hopes for future partnering - the solution for struggling fairs
Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Hey Klementina Österberg ...
... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.
-
Rapid system for surface hygiene monitoring
The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...
-
Hon tar plats i Senzimes styrelse
Olinks marknadsdirektör är ny ledamot i Senzimes styrelse.
-
Storägare vill förhandla
Fondbolaget Blackrock och kapitalförvaltaren Grantham Mayo uppmanar Astrazenecas styrelse att hålla nya samtal med Pfizer.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Grönländsk genvariant påverkar diabetes
Andelenfall av typ 2-diabetes på Grönland har ökat dramatiskt de 25 senaste åren. En del av förklaringen ligger i generna. Det visar Niels Grarups forskning och...
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
BMAs: Run your own business
After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...
-
Smuggling för miljarder
Läkemedel för 200 miljarder dollar - så stort är värdet på förfalskningsmarknaden visar en ny undersökning.
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Ny chef på Bactiguard
I augusti tillträder Gabriella Björknert Caracciolo som ny CFO samt vice vd på Bactiguard.
-
Anställer tolv nya bioinformatiker
Plattformen för bioinformatik växer och Scilifelab startar upp ett mentorprogram.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
BREAKING